Osteoporosis prevention, diagnosis and management in postmenopausal women and men over 50 years of age

Recommendations

Hip protectors

Osteoporosis prevention, diagnosis and management in postmenopausal women and men over 50 years of a
Download PDF
  1. Summary of recommendations
  3. Figures and tables
  4. Appendix A. Process report
  5. Appendix B. Working group
  6. Provided under licence

Evidence statement

A Cochrane review1 of pooled of data from 14 studies (11,808 participants) conducted in nursing or residential-care settings found moderate-quality evidence for a small reduction in hip fracture risk (relative risk [RR]: 0.82, 95% confidence interval [CI]: 0.67–1.00); the absolute effect is 11 fewer people (95% CI, from fewer than 20 to 0) per 1000 having a hip fracture when provided with hip protectors. There is moderatequality evidence when pooling data from five trials in the community (5614 participants) that shows little or no effect in hip fracture risk (RR: 1.15, 95% CI: 0.84–1.58).1

Grade: C

Recommendation 28
Consider the use of hip protectors to reduce the risk of hip fracture in residential-care settings, but not in community settings.

  1. Santesso N, Carrasco-Labra A, Brignardello-Petersen R. Hip protectors for preventing hip fractures in older people. Cochrane Database Syst Rev 2014.10.1002/14651858.CD001255.pub5.
This event attracts CPD points and can be self recorded

Did you know you can now log your CPD with a click of a button?

Create Quick log

Related documents

  Osteoporosis-flowchart.pdf (PDF 0.98 MB)

Advertising